WuXi Biologics gets recognition at Biopharma Industry Awards

WuXi Biologics, a Hong Kong, S.A.R., China-listed company, received Asia's CMO of 2017 at the 8th Annual BioPharma Industry Awards Ceremony recently.

The BioPharma Industry Awards Ceremony was held at 2018 Phar-East Asia Pharma & Biotech Festival on 1st March, 2018. The Biopharma Industry Awards aims to recognize the efforts, accomplishments and positive contributions of organizations and individuals in Asia's biopharmaceutical industry.

In December 2017, the company's biologics cGMP manufacturing facility in Wuxi city with 30,000 L bioreactor capacity entered into full operation. The new facility quintupled the existing manufacturing capability of WuXi Biologics and further strengthened its position as a global premier biologics manufacturer. The new facility in Wuxi delivered additional capacity, greater flexibility and higher efficiency to WuXi Biologics' customers.

Register as Visitor to CPhI China 2018!